Log in
Enquire now
Genomes.io

Genomes.io

Genomes.io is a project for securing individual genomic data privately using a blockchain.

OverviewStructured DataIssuesContributors

Contents

genomes.io
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Decentralized Science (DeSci)
Decentralized Science (DeSci)
Health technology
Health technology
Biotechnology
Biotechnology
Location
London
London
0
B2X
B2C
B2C
0
B2B
B2B
0
Number of Employees (Ranges)
11 – 500
Investors
‌
GEM Digital UK Limited
Founded Date
2018
0
Total Funding Amount (USD)
21,000,000
Latest Funding Round Date
August 21, 2023
Also Known As
Genomes
Country
United Kingdom
United Kingdom
Headquarters
London
London

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
20,000,000

Genomes.io is a project for securing individual genomic data privately using a blockchain. Individuals can then approve access to their data by third party researchers in exchange for tokens (symbol: GENE). The gene tokens are secured using the Ethereum blockchain, while Rockchain is used to orchestrate access rights to genetic data.

Source: Genomes.io marketing video.

Genomes.io is a member of the Genomic Blockchain Consortium, an organization initiated by EncrypGen.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Blockchain enabled genome security from the moment it is sequenced

Mark Hahnel

http://www.genomes.io/wp-content/uploads/2018/02/The-genomes.io-Whitepaper-V-1.1.1.pdf

References

Find more companies like Genomes.io

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.